# A First-in-Human Study of JNJ-28431754 in Healthy Male Volunteers

> **NCT01177150** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 71 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-28431754/ Placebo
- **DRUG:** JNJ-28431754

## Key facts

- **NCT ID:** NCT01177150
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2010-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01177150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01177150, "A First-in-Human Study of JNJ-28431754 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01177150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*